Third Harmonic Bio Statistics
Total Valuation
THRD has a market cap or net worth of $561.88 million. The enterprise value is $269.19 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
THRD has 45.06 million shares outstanding. The number of shares has increased by 2.31% in one year.
| Current Share Class | 45.06M |
| Shares Outstanding | 45.06M |
| Shares Change (YoY) | +2.31% |
| Shares Change (QoQ) | +1.88% |
| Owned by Insiders (%) | 3.18% |
| Owned by Institutions (%) | 32.08% |
| Float | 13.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.89 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 42.50, with a Debt / Equity ratio of 0.01.
| Current Ratio | 42.50 |
| Quick Ratio | 41.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.81% and return on invested capital (ROIC) is -11.48%.
| Return on Equity (ROE) | -13.81% |
| Return on Assets (ROA) | -11.26% |
| Return on Capital (ROIC) | -11.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +75.63% in the last 52 weeks. The beta is 2.86, so THRD's price volatility has been higher than the market average.
| Beta (5Y) | 2.86 |
| 52-Week Price Change | +75.63% |
| 50-Day Moving Average | 13.24 |
| 200-Day Moving Average | 12.06 |
| Relative Strength Index (RSI) | 46.72 |
| Average Volume (20 Days) | 233,890 |
Short Selling Information
The latest short interest is 2.88 million, so 6.38% of the outstanding shares have been sold short.
| Short Interest | 2.88M |
| Short Previous Month | 2.78M |
| Short % of Shares Out | 6.38% |
| Short % of Float | 20.73% |
| Short Ratio (days to cover) | 20.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.84M |
| Pretax Income | -32.74M |
| Net Income | -39.20M |
| EBITDA | -52.79M |
| EBIT | -52.84M |
| Earnings Per Share (EPS) | -$0.97 |
Full Income StatementBalance Sheet
The company has $296.09 million in cash and $3.40 million in debt, giving a net cash position of $292.69 million or $6.50 per share.
| Cash & Cash Equivalents | 296.09M |
| Total Debt | 3.40M |
| Net Cash | 292.69M |
| Net Cash Per Share | $6.50 |
| Equity (Book Value) | 294.85M |
| Book Value Per Share | 6.59 |
| Working Capital | 293.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.88 million and capital expenditures -$1,000, giving a free cash flow of -$28.88 million.
| Operating Cash Flow | -28.88M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -28.88M |
| FCF Per Share | -$0.64 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |